ARCHIVES

FDA Approves Two Oral Drugs For Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

IVAX And It’s Portfolio

December 22, 1994

DeVita Suggest “Overlay Consortium” as Outreach Mechanism for Southern California, Other Areas

September 28, 1984

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999